Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2021

Fuse Biotherapeutics, Inc

Offering
$9.6M
Sold
$8.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Brian Rabinovich · Los Angeles, CAExec · DirectorPaul Song · Los Angeles, CAExec · DirectorJeffrey Takimoto · Los Angeles, CAExecYuanheng W. Liang · Los Angeles, CADirectorYi Fan · Hong Kong, Hong KongExec · DirectorAshwin Datta · HILLSBORO, ORDirectorChristopher Pallotta · New York, NYExecTrevor Bachand · HILLSBORO, ORExec · DirectorJacob A. Puig · Laredo, TXDirectorGerardo M. Sanchez · Laredo, TXExec · DirectorJamey A. Steen · Houston, TXExec · DirectorSteven Howard · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗